A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Clinical trial NCT04381650 · COMPLETED

Trial details

NCT number: NCT04381650
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors

Start date: 2020-08-17
Primary completion: 2024-10-29
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.